Brief: Anixa Biosciences Announces Completion Of Enrollment In Phase 1 Trial Of Breast Cancer Vaccine
02/06/2025 13:23
June 2 (Reuters) - Anixa Biosciences Inc ANIX.O: ANIXA BIOSCIENCES ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 1 TRIAL OF BREAST CANCER VACCINE Source text: ID:nPnb4mgpfa Further company coverage: ANIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine